The last few decades have witnessed a continued surge in the prevalence of metabolic disorders, such as obesity, dyslipidemia, insulin resistance, and diabetes mellitus, which pose a significant public health concern. However, recent evidence from scientific community put forth the pathognomonic role of altered gut microbiota composition and diversity as one of the probable factors in the development and increased global incidence of metabolic disorders, especially obesity and diabetes.